LETTER OF INTENT RECEIPT DATE: FEBRUARY 15, 2005
APPLICATION RECEIPT DATE: MARCH 1, 2005
We are at the beginning of a major breakthrough in cancer control. The
explosion in knowledge of gene sequence and function, fueled in large part
by the Human Genome Project is already transforming how patients and
physicians evaluate risk, prevention, detection, and the treatment of
cancer. Emerging technologies are enabling rapid, cost-effective, and
coordinate evaluation of an individual’s DNA sequence and complex patterns
of RNA and protein expression. This in turn, presents us with the
challenges of translating such knowledge into clinical management.
Canary Fund in partnership with the American Cancer Society has created a
postdoctoral fellowship program focused on studies in the tools and
technologies for developing strategies for the early detection of cancer.
Research should be directed at new approaches to improve clinical methods
for the screening of cancer including, but not limited to, research focused
in the following areas:
• Minimally invasive strategies for early detection
• Biomarker identification or discovery, particularly protein
biomarkers
• Imaging, including novel molecular imaging strategies
Awards will be 3 years in duration with progressive stipends of $40,000,
$42,000, and $44,000 per year, plus $4,000 per year for institutional
allowance. Based upon the availability of funds and the scientific merit
of the applications, it is anticipated that up to 5 awards will be
made. To reserve funding for full 3 year fellowships, applications will
only be accepted from scientists who at the time of application have had no
more than 2 years of research experience beyond their terminal degree (MD
or PhD). Applicants must be US citizens or permanent residents working
with an accomplished mentor at a non-profit institution. Postdoctoral
fellowships are designed to support a program of research training and
study to enable new investigators to develop the critical skills necessary
for an independent career in cancer research.
The deadline for receipt of applications is March 1, 2005. A letter of
intent is required and should be submitted by February 15th. It should
provide the title of the project, a brief summary of the specific aims, and
an outline (2-3 sentences) of the techniques to be used to achieve the
aims. Awardees will be asked to attend the May 24-26, 2005 Early Detection
Symposium in Palo Alto, California. For additional information regarding
program policies or to obtain an application, please refer to the ACS
website: www.cancer.org/research
For specific inquiries, please contact:
Christopher Widnell, PhD
American Cancer Society, Inc.
404-329-7552
christopher.widnell
dnell@cancer.org>@cancer.org
or
William Phelps, PhD
American Cancer Society, Inc.
404-329-6835
william.phelps@cancer.
ancer.org>org
